NGeneBio Co., Ltd. (KOSDAQ:354200)
South Korea
· Delayed Price · Currency is KRW
1,954.00
-81.00 (-3.98%)
At close: Mar 9, 2026
NGeneBio Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 51,030 | 32,411 | 71,664 | 116,027 | 201,381 |
| Market Cap Growth | 49.61% | -54.77% | -38.23% | -42.38% | - |
| Enterprise Value | 61,309 | 40,754 | 56,797 | 89,239 | - |
| Last Close Price | 1954.00 | 1642.00 | 4897.30 | 8173.92 | 14269.12 |
| PS Ratio | 5.11 | 5.70 | 16.47 | 10.53 | 28.11 |
| PB Ratio | 3.23 | 1.83 | 4.41 | 4.58 | 5.92 |
| P/TBV Ratio | 4.74 | 3.54 | 4.97 | 4.91 | 6.23 |
| EV/Sales Ratio | 6.14 | 7.16 | 13.05 | 8.10 | - |
| Debt / Equity Ratio | 1.05 | 0.51 | 0.71 | 0.45 | 0.21 |
| Net Debt / Equity Ratio | 0.67 | 0.09 | -0.68 | -0.93 | -0.50 |
| Net Debt / EBITDA Ratio | -1.00 | -0.12 | 0.91 | 3.20 | 2.22 |
| Net Debt / FCF Ratio | -1.19 | -0.12 | 1.15 | 2.65 | 1.62 |
| Asset Turnover | 0.26 | 0.15 | 0.09 | 0.22 | - |
| Inventory Turnover | 4.42 | 1.91 | 1.93 | 3.29 | - |
| Quick Ratio | 0.79 | 0.66 | 0.98 | 1.25 | 3.22 |
| Current Ratio | 0.93 | 0.93 | 1.14 | 1.49 | 3.40 |
| Return on Equity (ROE) | -108.49% | -82.15% | -61.88% | -33.17% | - |
| Return on Assets (ROA) | -21.45% | -26.71% | -17.05% | -10.75% | - |
| Return on Capital Employed (ROCE) | -77.10% | -78.70% | -72.70% | -31.70% | -24.40% |
| Earnings Yield | -25.39% | -38.96% | -17.82% | -8.43% | -4.19% |
| FCF Yield | -17.36% | -38.77% | -13.33% | -7.63% | -5.24% |
| Buyback Yield / Dilution | -60.90% | -31.30% | -1.66% | -0.89% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.